NCT05352750View on ClinicalTrials.gov

Phase 1 Study of SON-1010 in Adult Patients With Advanced Solid Tumors

PHASE1UnknownINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

April 20, 2022

Primary Completion Date

December 30, 2024

Study Completion Date

December 31, 2024

Conditions
Advanced Solid Tumor
Interventions
BIOLOGICAL

SON-1010

SON-1010 multiple ascending dose

Trial Locations (1)

90403

RECRUITING

Sarcoma Oncology Center, Santa Monica

Sponsors
All Listed Sponsors
lead

Sonnet BioTherapeutics

INDUSTRY

NCT05352750 - Phase 1 Study of SON-1010 in Adult Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter